‘Joyalukkas Think Pink' to urge people to take the Pink Pledge with an increased drive to build awareness and educate on Breast Cancer.
Dubai, 6th October, 2013: The ‘Joyalukkas Think Pink' initiative, with the theme ‘Take a Pink Pledge,' launched once again this October is part of the Joyalukkas commitment to reinforce and build awareness of the fight against breast cancer. The mega CSR initiative is supported by the esteemed Zuleka Hospital and Dubai Health Authority. The ‘Joyalukkas Think Pink' campaign is a non-profit initiative with the single minded objective to educate and inform all on the disease.
The month of October is celebrated world-wide as the month dedicated to building awareness, educating and empowering women on Breast Cancer. To complement the global drive, Joyalukkas launched ‘Think Pink' in the year 2011, as one of its main activities within its yearly CSR calendar. The Joyalukkas ‘Think Pink' initiative in association with Zulekha Hospital strives to drive awareness and educate society on the various aspects of breast cancer, including detection, via various media and in-store activities.
“This year we are making an increased drive towards educating and empowering women since we have received a positive response over the last two years. I would like to sincerely thank the esteemed Dubai Health Authority for supporting this drive and helping us to extend our reach to more people and educate them on this disease. I would like to especially thank Zuleka Hospital for the support it has extended to us in our endeavor,” said Joy Alukkas, Chairman & MD, Joyalukkas Group.
‘Joyalukkas Think Pink' was launched with an official function on 6th October 2013 in Dubai where pink balloons were released by Dr Ahmad bin Kalban, CEO of Primary Healthcare at Dubai Health Authority (DHA) as a symbolic gesture towards the cause. Also in attendance at the launch was Dr. Pamela Munster, renowned breast cancer research specialist, Professor, Department of Medicine (Haematology/Oncology), University of California, San Francisco (UCSF), Director, Early Phase Clinical Trials Unit and Leader, Developmental Therapeutics Program, UCSF Helen Diller Family Comprehensive Cancer Center. Several official dignitaries and eminent doctors from the field of breast cancer research were also present at the occasion.
“According to the World Health Organisation (WHO), one third of cancer deaths could be reduced with early detection. In a worldwide context, this equates to 400,000 lives every year. Breast cancer is the most common form of cancer among women, yet, despite its prevalence, not enough cases are caught in the early stages and the longer a cancer goes undetected, the harder it is for doctors to tackle it and for patients to survive. Therefore, such awareness campaigns are vital to educate women and their family members about the importance of regular screenings to detect breast cancer early on. The DHA would like to encourage not only women but also their family members to be educated about breast cancer so that they can encourage women above the age of 40 in their family to undergo yearly breast cancer screenings,” said Dr Ahmad bin Kalban, CEO of Primary Healthcare at Dubai Health Authority (DHA).
Under the ‘Joyalukkas Think Pink' umbrella, a mass media campaign will be launched to build awareness and educate women on breast cancer. The campaign will also include free breast consultation vouchers distributed at Zulekha hospital and a special educational booklet, distributed across the UAE, which will detail self detection methods in addition to key facts of the disease plus feature articles and quotes from reputed personalities in support of this grand initiative. Other than this there are special orientation programs planned in universities, schools, Government offices and various Corporates across the UAE.
“Our pledge to fight breast cancer has grown stronger with the overwhelming support and response we have received in the past two years, hence we have decided to further our activities under the ‘Think Pink' banner. As a Group, we are committed to take up causes that help and assist mankind and we hope we manage to reinforce the fight against breast cancer once again this October,” said John Paul Joy Alukkas, Executive Director, Joyalukkas Group.
“As a healthcare provider we feel it is our responsibility to support and do everything possible that result in the health and well-being of people. The emphasis of the ‘Joyalukkas Think Pink' initiative is to build awareness about breast cancer and educate them on taking preventive measures. While women over 40 years of age are globally the most affected, younger women now are also being diagnosed with the disease, women as young as 19 to 30 have been diagnosed with breast cancer in the UAE. We hope ‘Joyalukkas Think Pink' will add to the activities undertaken by various bodies to build awareness, educate and protect women” said Dr. Zulekha Daud, Managing Director, Zulekha Healthcare Group.
Under the ‘Joyalukkas Think Pink' umbrella, various road shows and activities targeting women have been planned to give them a forum in which concerns and questions about breast cancer may be raised. Popular radio stations across the UAE will also be used as a medium to interact live with listeners, hear their stories and most importantly to educate and build awareness.
About Joyalukkas Group
Joyalukkas Group is a multi-billion dollar global conglomerate with varied business interests. The group operates its various business operations across Singapore, Malaysia, UK, India, UAE, Saudi Arabia, Bahrain, Oman, Kuwait and Qatar. The group businesses include jewellery retail, money exchange, fashion & textiles, luxury air charter & malls. Joyalukkas employs over 6,000 professionals worldwide and is one of the most awarded and recognized jewellery retail chains in the world. www.joyalukkas.com
About the Dubai Health Authority:
The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement. His Highness Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai and UAE Minister of Finance is the President of the Dubai Health Authority and His Excellency Engineer Essa Al Maidoor is the Director-General of the DHA.
The DHA's aim in Dubai is to provide an accessible, effective and integrated healthcare system, protect public health and improve the quality of life within the Emirate. This is a direct translation of the objectives of the Dubai Strategic Plan 2015 launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum. Keeping the strategic plan in mind, the DHA's mission is to ensure access to health services, maintain and improve the quality of these services, improve the health status of nationals, residents and visitors and oversee a dynamic, efficient and innovative health sector.
In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including hospitals (Latifa, Dubai, Rashid and Hatta), specialty centres (e.g. the Dubai Diabetes Center) and DHA primary health centres spread throughout the Emirate of Dubai.
The main pillars of service delivery at DHA health facilities are quality, efficiency, patients and staff. It is our aim to maintain and improve the quality and efficiency of DHA health services. An important aspect of the service delivery strategy is to focus on patients, their needs and satisfaction as well as attract, retain, nurture and support outstanding staff.
Prior to the establishment of the DHA, the Department of Health and Medical Services (DOHMS), which was established in 1973, was the functioning authority that almost exclusively focused on health service delivery.
About Zulekha Healthcare Group
Zulekha Healthcare Group is one of the region's foremost brands for comprehensive healthcare. The group has healthcare facilities in Dubai and Sharjah, with their hospitals and medical centre chain in Dubai and Sharjah accredited by the Joint Commission International, College of American Pathologists for Lab services and Dubai Quality Award for Quality and Customer experience.